Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Gilead’s HIV capsid inhibitor might need dosing only every six months
Abnormal anal screening results are common, but they often do not to lead to invasive cancer.
Future research should examine how particular combinations of antiretrovirals contribute to weight gain, according to one expert.
Rates of HIV acquisition were very low among people taking Descovy or Truvada, but Descovy had less effect on kidneys and bones.
Studies indicate that there is a very low likelihood that people with HIV have preexisting resistance to the medication.
The integrase inhibitor–based HIV regimen was compared with dolutegravir-based regimens.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.